Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, 1120 15th Street, CB 1114, Augusta, GA, 30912-2000, USA.
James and Jean Culver Vision Discovery Institute, Medical College of Georgia (MCG), Augusta University, Augusta, GA, 30912, USA.
J Mol Med (Berl). 2021 Jan;99(1):119-130. doi: 10.1007/s00109-020-02000-y. Epub 2020 Nov 6.
Elevated levels of amino acid homocysteine (Hcy) recognized as hyperhomocysteinemia (HHcy) was reported in several human visual disorders, such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). Breakdown of blood-retinal barrier (BRB) is concomitant with vision loss in DR and AMD. We previously reported that HHcy alters BRB. Here, we tested the hypothesis that HHcy alters BRB via activation of N-methyl-D-aspartate receptor (NMDAR). Human retinal endothelial cells subjected to high level of Hcy and mouse model of HHcy were used. We injected Hcy intravitreal and used a mouse model of HHcy that lacks cystathionine-β-synthase (CBS). RT-PCR, western blot, and immunofluorescence showed that retinal endothelial cells (RECs) express NMDAR at the gene and protein levels both in vitro and in vivo and this was increased by HHcy. We assessed BRB function and retinal morphology using fluorescein angiogram and optical coherence tomography (OCT) under HHcy with and without pharmacological inhibition of NMDAR by (MK801) or in mice lacking endothelial NMDAR (NMDAR mouse). Additionally, retinal albumin leakage and tight junction proteins ZO-1 and occludin were assessed by western blotting analysis. Inhibition or elimination of NMDAR was able to improve the altered retinal hyperpermeability and morphology under HHcy as indicated by significant decrease in retinal albumin leakage and restoration of tight junction proteins ZO-1 and occludin. Our findings underscore a potential role for endothelial NMDAR in mediating Hcy-induced breakdown of BRB and subsequently as a potential therapeutic target in retinal diseases associated with HHcy such as DR and AMD. KEY MESSAGES: • Elevated levels of homocysteine (Hcy) are defined as hyperhomocysteinemia (HHcy). • HHcy is implicated in diabetic retinopathy and age-related macular degeneration. • HHcy alters BRB via activation of N-methyl-D-aspartate receptor.
血液视网膜屏障(BRB)的破坏伴随着糖尿病视网膜病变(DR)和年龄相关性黄斑变性(AMD)的视力丧失。我们之前报道过高同型半胱氨酸血症(HHcy)会改变 BRB。在这里,我们通过检测 HHcy 是否通过激活 N-甲基-D-天冬氨酸受体(NMDAR)来改变 BRB 的假说。使用高同型半胱氨酸的人视网膜内皮细胞和 HHcy 模型小鼠进行了这项研究。我们向玻璃体内注射同型半胱氨酸,并使用缺乏胱硫醚-β-合酶(CBS)的 HHcy 模型小鼠。RT-PCR、western blot 和免疫荧光显示,视网膜内皮细胞(RECs)在体外和体内均在基因和蛋白水平上表达 NMDAR,并且这种表达在 HHcy 条件下增加。我们在 HHcy 条件下使用荧光素血管造影和光学相干断层扫描(OCT)评估 BRB 功能和视网膜形态,同时使用 NMDAR 的药理学抑制剂(MK801)或在缺乏内皮 NMDAR(NMDAR 小鼠)的小鼠中进行抑制。此外,通过 western blot 分析评估视网膜白蛋白渗漏和紧密连接蛋白 ZO-1 和 occludin。抑制或消除 NMDAR 能够改善 HHcy 下改变的视网膜高通透性和形态,表现为视网膜白蛋白渗漏显著减少以及紧密连接蛋白 ZO-1 和 occludin 恢复。我们的研究结果强调了内皮 NMDAR 在介导同型半胱氨酸诱导的 BRB 破坏中的潜在作用,并且可能成为与 HHcy 相关的视网膜疾病(如 DR 和 AMD)的潜在治疗靶点。
同型半胱氨酸(Hcy)水平升高定义为高同型半胱氨酸血症(HHcy)。
HHcy 与糖尿病视网膜病变和年龄相关性黄斑变性有关。
HHcy 通过激活 N-甲基-D-天冬氨酸受体改变 BRB。